Moleculin Biotech Inc buy melinda
Summary
This prediction ended on 28.08.18 with a price of €9.20. The prediction for Moleculin Biotech Inc disappointed with a performance of -17.48%. melinda has 50% into this predictionMoleculin Biotech (Symbol: MBRX) is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing a broad range of innovative cancer treatments. With a diversified portfolio of drug candidates targeting difficult-to-treat cancers, including leukemia, lung, and pancreatic tumors, MBRX leverages cutting-edge scientific research and expertise to develop drugs that aim to provide improved patient outcomes. The company's innovative approach includes utilizing metabolic inhibitors, immune-globulin-like transcript 3 (ILT3) inhibitors, and STAT3 inhibitors as key weapons in the fight against cancer. As Moleculin Biotech advances its drug candidates through clinical trials, it holds the promise of bringing novel cancer therapies to market, potentially improving the lives of cancer patients globally.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Moleculin Biotech Inc | - | - | - | - |
iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by melinda for this prediction
In the thread Moleculin Biotech Inc diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 | Spezielle Mitteilung 22.30
Zur Erinnerung: Moleculin kündigt Telefonkonferenz zur Erörterung der jüngsten Entdeckung neuer Molecule und Business Update am Mittwoch, den 28. Februar 2018
HOUSTON, TX - (Marketwire - 28. Februar 2018) - Moleculin Biotech, Inc. (NASDAQ: MBRX) ( "Moleculin" oder das "Unternehmen"), eine Famulatur pharmazeutischen Unternehmen, das sich auf die Entwicklung von anti ... ( Detail ) ,
Moleculin Biotech, Inc. 28. Februar. 2018 10.05 ET
Stopped prediction by melinda for Moleculin Biotech Inc
Moleculin Biotech Inc
15.07.20
04.11.21
05.11.21
Moleculin Biotech Inc
21.04.19
22.04.19
22.04.19
Moleculin Biotech Inc
30.08.18
23.01.19
23.01.19
Moleculin Biotech Inc
29.06.17
19.12.17
19.12.17
Moleculin Biotech Inc
29.06.17
19.12.17
19.12.17
Moleculin Biotech Inc
27.06.17
27.06.17
27.06.17
Moleculin Biotech Inc
22.06.17
27.06.17
27.06.17